PureTech Health (GB:PRTC) has released an update.
PureTech Health has announced the appointment of Michele Holcomb, PhD, to its board of directors, effective September 23, 2024. Dr. Holcomb is a seasoned healthcare leader with over three decades of experience in the industry, having held strategic roles at Cardinal Health, Teva Pharmaceuticals, and McKinsey & Company. Her expertise is expected to drive PureTech’s growth and innovation, particularly as they focus on bringing new medicines to patients and enhancing shareholder value.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
